IL310759A - Methods and preparations for the treatment of cancer - Google Patents
Methods and preparations for the treatment of cancerInfo
- Publication number
- IL310759A IL310759A IL310759A IL31075924A IL310759A IL 310759 A IL310759 A IL 310759A IL 310759 A IL310759 A IL 310759A IL 31075924 A IL31075924 A IL 31075924A IL 310759 A IL310759 A IL 310759A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- treating cancer
- cancer
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232409P | 2021-08-12 | 2021-08-12 | |
| PCT/US2022/040092 WO2023018891A1 (en) | 2021-08-12 | 2022-08-11 | Methods and compositions for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310759A true IL310759A (en) | 2024-04-01 |
Family
ID=85200519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310759A IL310759A (en) | 2021-08-12 | 2022-08-11 | Methods and preparations for the treatment of cancer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240299326A1 (https=) |
| EP (1) | EP4384498A1 (https=) |
| JP (1) | JP2024531238A (https=) |
| CN (1) | CN118076583A (https=) |
| AU (1) | AU2022326485A1 (https=) |
| CA (1) | CA3228644A1 (https=) |
| CO (1) | CO2024002786A2 (https=) |
| GB (1) | GB2628229A (https=) |
| IL (1) | IL310759A (https=) |
| MX (1) | MX2024001935A (https=) |
| WO (1) | WO2023018891A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5156389B2 (ja) * | 2005-01-05 | 2013-03-06 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | 薬剤耐性増殖性疾患の治療剤 |
| WO2014089483A1 (en) * | 2012-12-07 | 2014-06-12 | Onconova Therapeutics, Inc. | Methods and compositions for treatment of cancer |
| JP2018530590A (ja) * | 2015-10-14 | 2018-10-18 | タリックス ファーマシューティカルズ リミテッド | 表皮水疱症の処置のための方法及び組成物 |
| CA3076610A1 (en) * | 2017-09-22 | 2019-03-28 | University Of Miami | Methods and compositions for the treatment of epidermolysis bullosa |
-
2022
- 2022-08-11 CA CA3228644A patent/CA3228644A1/en active Pending
- 2022-08-11 JP JP2024508686A patent/JP2024531238A/ja active Pending
- 2022-08-11 MX MX2024001935A patent/MX2024001935A/es unknown
- 2022-08-11 WO PCT/US2022/040092 patent/WO2023018891A1/en not_active Ceased
- 2022-08-11 AU AU2022326485A patent/AU2022326485A1/en active Pending
- 2022-08-11 IL IL310759A patent/IL310759A/en unknown
- 2022-08-11 GB GB2402730.2A patent/GB2628229A/en active Pending
- 2022-08-11 EP EP22856622.0A patent/EP4384498A1/en active Pending
- 2022-08-11 CN CN202280068270.9A patent/CN118076583A/zh active Pending
-
2024
- 2024-02-09 US US18/437,793 patent/US20240299326A1/en active Pending
- 2024-03-06 CO CONC2024/0002786A patent/CO2024002786A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023018891A1 (en) | 2023-02-16 |
| US20240299326A1 (en) | 2024-09-12 |
| GB2628229A (en) | 2024-09-18 |
| AU2022326485A1 (en) | 2024-02-29 |
| MX2024001935A (es) | 2024-03-21 |
| CO2024002786A2 (es) | 2024-03-18 |
| GB202402730D0 (en) | 2024-04-10 |
| CA3228644A1 (en) | 2023-02-16 |
| CN118076583A (zh) | 2024-05-24 |
| WO2023018891A8 (en) | 2023-09-21 |
| JP2024531238A (ja) | 2024-08-29 |
| EP4384498A1 (en) | 2024-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286350A (en) | Preparations and methods for the treatment of cancer | |
| ZA202006627B (en) | Methods and compositions for treating cancer | |
| IL288914A (en) | Preparations and methods for the treatment of cancer | |
| ZA202104870B (en) | Methods and compositions for treating cancer | |
| EP4025590A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
| SG11202109336UA (en) | Methods and compositions for treating cancer | |
| IL287982A (en) | Preparations and methods for the treatment of cancer | |
| SG11202012435UA (en) | Compositions and methods for treating cancer | |
| IL315800A (en) | Preparations and methods for the treatment of cancer | |
| IL286153A (en) | Methods and preparations for the treatment of cancer | |
| IL309662A (en) | Compositions and methods for treating cancers | |
| IL309120A (en) | Methods and compositions for the treatment of cancer | |
| IL309071A (en) | Methods and compositions for the treatment of cancer | |
| EP4077690A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
| EP4149508A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF CANCER | |
| IL287538A (en) | Preparations and methods for the treatment of cancer | |
| IL312846A (en) | Methods and preparations for the treatment of cancer | |
| IL299039A (en) | Methods and preparations for the treatment of triple-negative breast cancer | |
| SG11202104692VA (en) | Compositions and methods for treating cancer | |
| IL308530A (en) | Preparations and methods for treating lung cancer | |
| IL285036A (en) | Methods and preparations for the treatment of cancer | |
| EP4243835A4 (en) | COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER | |
| GB202402730D0 (en) | Methods and compositions for treating cancer | |
| IL319543A (en) | Cancer treatment compositions and methods | |
| IL316053A (en) | Preparations and methods for the treatment of solid cancer |